ML021910130

Emergency Procedure EP-PS-132, Rev 10, OSC Coordinator: Emergency Plan Position Specific Procedure for Susquehanna Units 1 & 2

ML021910130
Person / Time
Site:	Susquehanna
Issue date:	07/02/2002
From:	Pennsylvania Power & Light Co
To:	Document Control Desk, Office of Nuclear Security and Incident Response
References
Download: ML021910130 (16)

Text

Jul.

02, 2002 Page 1

of 1

MANUAL HARD COPY DISTRIBUTION DOCUMENT TRANSMITTAL 2002-319/0 USER INFORMATION:

FLAIIVLAUR EL B

EMPL#:23244 CA#:

0386

• <dJcss.

N*UCCA2 Phone#:

254-3658 TRANSMITTAL INFORMATION:

TO-FLAIULAU RLL '

07/02/2002 LOCATION:

DOCUMENT CONTROL DESK FROM:

NUCLEAR RECORDS DOCUMENT CONTROL CENTER NUCSA-2)

L.....fHE FOLLOWING CHANGES HAVE OCCURRED TO THE HARDCOPY OR ELECTRONIC MANUAL ASSIGNED TO YOU:

132 132 OSC COORDINATOR:

EMERGENCY PLAN POSITION SPECIFIC PROCEDURE REMOVE MANUAL TABLE OF CONTENTS DATE:

05/24/2002 ADD MANUAL TABLE OF CONTENTS DATE:

07/01/2002 CATEGORY:

PROCEDURES TYPE:

EP ID:

EP-PS-132 ADD:

PCAF 2002-1442 REV:

N/A UPDATES FOR HARD COPY MANUALS WILL BE DISTRIBUTED WITHIN 5

DAYS IN ACCORDANCE WITH DEPARTMENT PROCEDURES.

PLEASE MAKE ALL CHANGES AND ACKNOWLEDGE COMPLETE IN YOUR NIMS INBOX UPON RECEIPT OF HARD COPY.

FOR ELECTRONIC MANUAL USERS, ELECTRONICALLY REVIEW THE APPROPRIATE DOCUMENTS AND ACKNOWLEDGE COMPLETE IN YOUR NIMS INBOX.

/

S.......

> 0

PROCEDURE CHANGE PROCESS FORM

1. PCAF NO.

2002-1442

12. PAGE 1 OF 5

13. PROC. NO.

EP-PS-132 REV. 10

4.

FORMS REVISED D

R 5, -5 R-,

R R_,

R-,

R

5.

PROCEDURE TITLE OSC Coordinator: Emergency Plan Position Specific Procedure

6.

REQUESTED CHANGE PERIODIC REVIEW

] NO r-YES INCORPORATE PCAFS [

NO r]

YES REVISION LI PCAF Z DELETION LI (CH*d-OE ONLY)

7.

SUMMARY

OF / REASON FOR CHANGE TAB D -Added Note prior to step 8, revised step 8 and added new step "Iiffirit e guidance for the OSC coordinator if the TSC mans the alternate TSC at the EOF. (Emerýd lan R vision 39)

Continued LI

8.

DETERMINE COMMITTEE REVIEW REQUIRE, (Refer to Section 6.1.4)

PORC REVIEW REQ'D,?

!Ndý I

E

9.

pORCMTG#

na BLOCKS 11 THRU 16ARE ON PAf 2 &,FO

17.

Cynthia Smith 94-3t3 05/30/2002

18. COMMUNICATION OF CHANGE REQUIRED?

PREPARER L'

ITN DATE I -NO Z YES (TYPE) memo (Print or Type)!!

oo,5

19. ~'SIGNATURE ATTESTS THAT RESPONSIBLE SUPERVISOR HAS

19.

CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.

ltPNBLE EVlSOR 7 'ATE"-

CROSS DISCIPLINE REVIEW (IF REQUIRED) HAS BEEN COMPLETED PT-BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.

20.

(j Q "LQd0IQL Z

- WM AýgROVAL DATE

21.

RESPONSIBLE APPROVER ENTER N/A IF FUM HAS APPROVAL AUTHORITY

INITIAU, DATE FORM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form)

PROCEDURE CHANGE PROCESS FORM

1. PCAF NO.

2002-1442

12.

PAGE 2 OF 5

13. PROC. NO. EP-PS-132 REV. 10

11.

This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either 1 la, b, c or d must be checked "YES" and the appropriate form attached or referenced.

a. This change is an Administrative Correction for which 50.59 and 72.48 are not

[

YES

] N/A applicable.

b. This change is a change to any surveillance, maintenance or administrative

YES r

N/A procedure for which 50.59 and 72.48 are not applicable.

,9-o / - 926.2

c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new

" YES

[

N/A 50.59/72.48.Evaluation is required.

Screen/Evaluation No.

d. 50.59 and/or 72.48 are applicable to this change and a 50.59/72.48 YES I

N/A Screen/Evaluation is attached.

12. This change is consistent with the FSAR or an FSAR change is required.

[

YES Change Request No.

na

13. Should this change be reviewed for potential effects on Training Needs or Material?

I YES NO If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN

14.

Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?

YES NO

15. Is a Special, Infrequent or Complex Test/Evolution Analysis Form required per LI YES

[

NO NDAP-QA-0320? (SICT/E form does not need to be attached.)

16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-0101-1.

REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR TECHNICAL REVIEW.

REACTOR ENGINEERING/NUCLEAR FUELS IST **

OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER 10CFR50.54Q Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (58)

"Required for changes to Section XI Inservice Test Acceptance Criteria.

FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Form)

1. 2002-1442 PAGE. OF..M.ý.U OSC COORDINATOR:

• WHEN:.

"HOW NOTIFIED:

..REPORT TO:

WHERE TO. REPORT: "

EP-PS-132 Revision 10 Page 2 of 3 Emergency Plan-Position Specific Procedure OSC is activated Radiolor-page Shift Supervisor Control Room, then the OSC OVERALL DUTY:

Dispatch teams in a controlled, safe manner so that the right information is supplied to those managing the emergency.

NAJOR TASKS:

TAB:

REVISION:

Obtain background on the emergency.

Assist in accounting for OSC responders.

Organize and manage people in the OSC.

When directed by the Emergency Director, assemble and dispatch In plant (India) teams.

Assemble and direct activities of the Search/Rescue/First Aid Team(s).

Work with the Security Coordinator or Controller.

Before the TSC is activated, assign and direct activities of the Chemistry Sampling Team(s).

If there is a liquid release, make sure samples are taken and analyzed by the Chemistry Staff and that any impacts on the Danville water Supply are determined.

When notified by the Emergency Director, assemble and assign Onsite (Oscar) Emergency Monitoring Teams.

TAB A TAB B TAB C TAB D TAB E TAB F 0

3 0

1 0

TAB G 2

TAB H I

I

PM

,, 2002-1442 PABMLýi?'

TAB D EP-PS-132-D RevisionA-4 Page 1 of 2

"_MAJOR TASK:

When directed by the Emergency Director, assemble and dispatch In-plant (India) teams.

SPECIFIC TASKS:

1.

Assign a team leader.

HOW:

Ia. Choose someone matched to the team's objective:

(1) Health Physics - HP Technician.

(2)

Security event - Security Officer.

(3) Fire or.System Degradation - Operations.

(4)

Chemical hazards someone from on-shift Chemistry.

(5) Others, as appropriate.

2.

Assemble the team.

3.

Brief the Team Leader and team.

4.

Consider possible impact of radiological information you've obtained.

5.

Assign team designation number.

3a.

Brief team on hazards.

3b.

Remind Team Leader to contact OSC Coordinator about every -10 minutes.

4a.

If necessary, apply for dose extensions febm the ED.

HELP.

PP&L Emergency Personnel Dose Assessment and PAR Guide See TAB 5 5a.

Update "OSC/TSC Briefing Sheet."

HELP OSC/TSC Briefing Sheet See TAB 3

PC

1. 2002-1442 6i eeqIuiree

6. Consider special requirements of various teams.

7.

Monitor team status on radio.

TAB D EP-PS-132-D Revision A-5

.Page 2 of 2 UnL.EIUl 6a.

Follow specific instructions for these teams in the TABs indicated:

(1) Search and Rescue - TAB E (2)

Chemistry Sampling - TAB F

(3)

Liquid Release -

TAB G 7a.

Contact the In-plant Leader if not notified of team status within 15 minutes.

7b.

Update Team Leader with any revised priorities and tasks.

NOTE: When control of emergency is assumed by the Technical Support Center (TSC) the OSC Coordinator will perform step 8 or 9 depending on where the TSC is located.

8.

When the TSC is activated onsite, the OSC Coordinator will relocate to the TSC.

9.

When the TSC is activated at its Alternate location (EOF), the OSC Coordinator will remain in the OSC.

8a.

Provide operations support to the Damage Control Teams.

8b.

Assist in damage assessment.

8c.

Make recommendations to Damage Control Team Coordinator.

8d.

Provide affected unit(s) and OSC Log Keeper with phone number you can be reached (recommend X3119, Damage Control Team Coordinator).

9a.

Continue control of inplant teams and support Operations as required..

9b.

Contact the Damage Control Team Coordinator at the EOF and status team activities.

SPFCIFIC TASKS-I I

Utll.!.

TAB 5 EP-PS-1 32-5 PP&L EMERGENCY PERSONNEL DOSE ASSESSMENT AND PROTECTIVE ACTION RECOMMENDATION (PAR) GUIDE TABLE OF CONTENTS Section Paage 1.0 EMERGENCY DOSE LIMITS 2.0 EMERGENCY EXPOSURE/ACCIDENTAL OVEREXPOSURE 3.0 PROTECTIVE ACTIONS 2

3 3

4 5

4.0 EMERGENCY EXPOSURE NOTIFICATION AND HEALTH CONSEQUENCE INVESTIGATION EMERGENCY EXPOSURE EXTENSIONS HEALTH PHYSICS AND ALARA CONSIDERATIONS DURING AN EMERGENCY EMERGENCY EXPOSURE EXTENSION REQUEST FORM and POTASSIUM IODIDE TRACKING FORM can be found immediately following EP-AD-000-125.

EP-AD-000-125, Revision 7, Page 1 of 10 8

TAB 5 EP-PS-1 32-5 PP&L EMERGENCY PERSONNEL DOSE ASSESSMENT AND PROTECTIVE ACTION RECOMMENDATION (PAR) GUIDE (continued)

CHECK 0 1.0 Limits for EMERGENCY doses.

D 1.1 An EMERGENCY DOSE AUTHORIZATION (see EMERGENCY EXPOSURE EXTENSIONS) may be granted in order to protect facilities, and or equipment to substantially limit the escape of radioactive effluents or control fires. The maximum planned doses are:

1.1.1 Whole body (TEDE)(1) dose shall not exceed 10 Rem.

1.1.2 Dose to any organ (CDE)(2), including the skin and extremity (SDE)(3),

shall not exceed 100 Rem.

1.1.3 Dose to the lens of the eye shall not exceed 30 Rem (LDE)(4 ).

0 1.2 An EMERGENCY dose authorization may be granted for life-saving actions or protection of large populations. The maximum doses are:

1.2.1 Planned whole body (TEDE)(1) doses shall not exceed 25 Rem.

1.2.2 Planned dose to any organ (CDE)(2), including skin and extremity doses, shall not exceed 250 Rem.

1.2.3 Dose to the lens of the eye shall not exceed 75 Rem (LDE)(4).

1.3 RARE situations may occur in which a dose GREATER THAN those specified in SECTION 1.2 above for emergency dose would be unavoidable to carry out a lifesaving operation or to avoid extensive exposure of large populations. It is not possible to prejudge the risk that one should be allowed to take to save lives of others, therefore no upper limit has been established.

(1) The sum of the Effective Dose Equivalent resulting from the exposure to external sources and the committed effective Dose Equivalent incurred from all significant inhalation pathways during the early phase.

(2) The Committed Dose Equivalent to the thyroid from radioiodine.

(3) Shallow Dose Equivalent.

(4) Lens Dose Equivalent.

EP-AD-000-125, Revision 7, Page 2 of 10

TAB 5 EP-PS-132-5 PP&L EMERGENCY PERSONNEL DOSE ASSESSMENT AND PROTECTIVE ACTION RECOMMENDATION (PAR) GUIDE (continued)

CHECK 0 2.0 For any EMERGENCY EXPOSURE OR ACCIDENTAL OVEREXPOSURE, the assessment actions in step 2 of the EMERGENCY EXPOSURE EXTENSIONS must be performed.

3.0 PROTECTIVE ACTIONS 0

3.1 Potassium Iodide 3.1.1 For emergency workers entering areas where a committed dose equivalent, (CDE)(2), to the thyroid from radioiodine could be 25 Rem or greater, the Consulting Radiological Physician should provide input concerning the administration and cessation of KI intake. (See Emergency Telephone Directory for telephone number.)

3.1.2 For thyroid exposures that are strongly expected to exceed 25 Rem, (CDE)(2), KI doses of 130 mg (100 mg - iodine) per day should be administered.

Unless the EMERGENCY DIRECTOR or RECOVERY MANAGER instructs personnel to do otherwise, the KI tablets should generally be taken as soon as possible after thyroid exposure exceeding 25 Rem (CDE)(2) is projected.

NOTE: Stable Iodine (KI) is most effective when administered immediately prior to exposure to radioiodine. Significant blockage of the thyroid dose can be provided by administration within one or two hours after uptake of radioiodine.

(1) The sum of the Effective 'Dose Equivalent resulting from the exposure to external sources and the committed effective Dose Equivalent incurred from all significant inhalation pathways during the early phase.

(2) The Committed Dose Equivalent to the thyroid from radioiodine.

(3)

Shallow Dose Equivalent.

(4) Lens Dose Equivalent.

EP-AD-000-125, Revision 7, Page 3 of 10

TAB 5 EP-PS-132-5 PP&L EMERGENCY PERSONNEL DOSE ASSESSMENT AND PROTECTIVE ACTION RECOMMENDATION (PAR) GUIDE (continued)

CHECK El 3.1.3 Onsite issuance of KI for iodine prophylaxis requires the approval of the EMERGENCY DIRECTOR. Issuance to EOF and FIELD EMERGENCY MONITORING/SAMPLING TEAM personnel requires the approval of the RECOVERY MANAGER when the EOF has relieved the TSC of emergency management activities. The EMERGENCY DIRECTOR will approve issuance prior to that time.

These approvals must be documented on the POTASSIUM IODIDE (KI) TRACKING FORM.

3.1.4 For an injured and/or contaminated worker sent to a hospital for treatment, the patient will be under the care of the attending physician.

As such, plant procedures no longer apply and KI issuance will be at the discretion of the attending physician. The physician can rely on a senior Health Physics Technician Level II or Health Physics Management to provide the in-plant radiological data on which to base their decision.

0 3.2 Protective measures should be implemented for EOF personnel at the direction of the DOSE ASSESSMENT SUPERVISOR.

El 3.3. Exposures to members of local offsite support groups, (ambulance workers, fire fighters) shall not exceed 500 mrem (TEDE)(1 ) for the performance of support duties on the site of the Susquehanna SES.

4.0 EMERGENCY EXPOSURE NOTIFICATIONS AND A HEALTH CONSEQUENCE INVESTIGATION must be conducted for any emergency exposure as outlined in step 6 of the Emergency Exposure Extensions.

(1) The sum of the Effective Dose Equivalent resulting from the exposure to external sources and the committed effective Dose Equivalent incurred from all significant inhalation pathways during the early phase.

(2) The Committed Dose Equivalent to the thyroid from radioiodine.

(3)

Shallow Dose Equivalent.

(4) Lens Dose Equivalent.

EP-AD-000-125, Revision 7, Page 4 of 10

TAB 5 EP-PS-1 32-5 EMERGENCY EXPOSURE EXTENSIONS CHECK El

1.

Fill out the attached EMERGENCY EXPOSURE EXTENSION REQUEST Form.

2.

Review the following factors:

"El Rescue personnel should be volunteers or professional rescuers.

"El Other considerations being equal (e.g., skill, potential need for person on another mission) personnel above the age of 45 are preferred.

"El Rescue personnel should be familiar and briefed with the consequences of exposure.

"El Women capable of reproduction should not take part in an effort requiring EMERGENCY exposure.

"El Use of personnel with high lifetime cumulative exposure should be discouraged.

El All reasonable measures must be taken to control contamination and internal exposure.

El Exposure under these conditions shall be limited to once in a lifetime.

El For exposures greater than 25 Rem whole body (TEDE), the persons undertaking any emergency operation in which the dose will exceed 25 Rem to the whole body (TEDE) should do so only on a voluntary basis and with full awareness of the risks involved, including the numerical levels of dose at which acute effects of radiation will be incurred and numerical estimates of the risk of delayed effects. See the following two tables for general information concerning Health Effects & Cancer Risks.

EP-AD-000-125, Revision 7, Page 5 of 10

TAB 5 EP-PS-1 32-5 EMERGENCY EXPOSURE EXTENSIONS (continued)

CHECK 0 Health Effects Associated with Whole Body Absorbed Doses Received Within a Few Hours(a)

Whole Body Absorbed Early Fatalitiesb Whole Body Absorbed Prodromal Effectsc Dose (rad)

(percent)

Dose (rad)

(percent affected) 140 5

50 2

200 15 100 15 300 50 150 50 400 85 200 85 460 95 250 98 a

Risks will be lower for protracted exposure periods.

b Supportive medical treatment may increase the dose at which these frequencies occur by approximately 50 percent.

c Symptoms (nausea, vomiting) which occur within a few hours after exposure to large doses of radiation and which usually precede more serious health effects.

Approximate Cancer Risk to Average Individuals from 25 Rem Effective Dose Equivalent Delivered Promptly Average Years of Life Lost if Age at Exposure Approximate Risk of Premature Death Premature Death Occurs (years)

(deaths per 1,000 persons exposed)

(years) 20 to 30 9.1 24 30to 40 7.2 19 40 to 50 5.3 15 50 to 60 3.5 11

3.

Review the HEALTH PHYSICS AND ALARA CONSIDERATIONS DURING EMERGENCIES which is attached.

4.

Obtain appropriate approval signatures as outlined in the table below.

EXTENSION APPROVAL ACTIONS FROM TO mrern mrem (TEDE)

(TEDE) 4000

<25000 ED and RPC/RM and DASU ALARA REVIEW AND APPLY EMERGENCY EXPOSURE CONSIDERATIONS ALL OF ABOVE AND

>25000 ED and RPC/RM and DASU BRIEFING ON RISKS EP-AD-000-125, Revision 7, Page 6 of 10

TAB 5 EP-PS-1 32-5 EMERGENCY EXPOSURE EXTENSIONS (continued)

CHECK 0

5.

If the Emergency Dose Extension is for greater that 4 Rem (TEDE), have the volunteer sign the EMERGENCY EXPOSURE REQUEST Form acknowledging that they are a volunteer and are fully aware of the radiological risks of acute and delayed effects.

6.

Upon completion of the activity requiring the Emergency Exposure perform the following:

"o Collect, process, and evaluate personnel dosimetry devices when technically appropriate.

"o Investigate the circumstances of all emergency exposures and confirm the dose received.

"o Notify the NRC of emergency exposure as follows:

Immediate notification of the NRC is required for:

a. Exposure of the whole body of greater than 25 Rem (TEDE); or

b. Exposure of the skin of the whole body of greater than 150 Rem (SDE); or

c. Exposure of the extremities of greater than 375 Rem (SDE).

Notification of the NRC within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> is required for:

a. Exposure of the whole body of greater than 5 Rem (TEDE); or

b. Exposure of the skin of the whole body of greater than 30 Rem (SDE); or

c. Exposure of the extremities of greater than 75 Rem (SDE).

"O Assess the health consequences of all emergency exposures. Consult with a physician to determine the need for and extent of physical and biochemical examinations.

"0 Whole body greater than 25 Rem (TEDE) should result in an examination of the exposed person by a physician.

"0 If internal exposure is suspected, quantitative measurements should be made immediately. Bioassays are required based on the following:

"* Nasal smear or facial contamination greater than 1,000 cpm above background.

"* Greater than 4 DAC-HRS in a day or less, or 20 DAC-HRS in a week or less.

EP-AD-000-125, Revision 7, Page 7 of 10

TAB 5 EP-PS-1 32-5 HEALTH PHYSICS AND ALARA CONSIDERATIONS DURING EMERGENCIES CHECK 0 1.0 Evaluate radiological conditions.

0 1.1 Obtain detailed survey data to ascertain:

1.1.1 Beta-Gamma radiation levels 1.1.2 Need for neutron measurements 1.1.3 Contamination levels and protective clothing requirements 1.1.4 Airborne radioactive materials 1.1.5 Variability of conditions over space and time 0

1.2 Evaluate personnel status.

1.2.1 Determine available dose under normal administrative dose objectives.

1.2.2 If essential, obtain approval from RADIATION PROTECTION COORDINATOR/EMERGENCY DIRECTOR for persons expected to exceed administrative objectives.

1.2.3 Follow criteria in PP&L Emergency Personnel Dose Assessment and Protective Action Recommendation Guide when emergency exposures are deemed appropriate by EMERGENCY DIRECTOR.

1.2.4 Assess individual's history of exposure to airborne materials.

1.2.5 Assess individual's skills in relation to proposed task.

1.2.6 Assess individual's lifetime exposure history.

EP-AD-000-125, Revision 7, Page 8 of 10

TAB 5 EP-PS-1 32-5 HEALTH PHYSICS AND ALARA CONSIDERATIONS DURING EMERGENCIES (continued)

CHECK 0 0

1.3 Determine proper type and placement of dosimeters.

1.3.1 Evaluate need for additional whole body dosimeters.

NOTE: For emergency exposures above 4 rem, the placement of several dosimeters on an individual is recommended to determine spatial distribution of dose to the individual.

1.3.2 Evaluate need and placement of extremity dosimeters.

1.3.3 Evaluate need for additional dosimetry devices such as high range self-reading dosimeters, electronic dosimeters, and neutron dosimeters.

1.3.4 Evaluate need for time keeping.

O 1.4 Determine proper respirator equipment required to perform task.

NOTE: For tasks expected to last more than several hours, consider need for relief of team members.

O 1.5 Review the following ALARA items:

NOTE: The detail and scope of ALARA reviews are to be commensurate with the magnitude of doses expected, numbers of people involved, and urgency of required task.

1.5.1 Consider the trend of exposures vs. the importance of the task:

a. Important and critical task with rising exposure rates will require the dispatch of teams as quickly as possible to reduce exposures.

b. Unimportant or less critical task could be delayed until exposure rates begin to trend downward.

EP-AD-000-125, Revision 7, Page 9 of 10

TAB 5 EP-PS-132-5 HEALTH PHYSICS AND ALARA CONSIDERATIONS DURING EMERGENCIES (continued)

CHECK El 1.5.2 When time permits the following should be included in the ALARA review:

a. Consider the use of remote handling devices or other special tools.

b. Consider the use of portable shielding.

c. Consider the need for mock-ups or other practice exercises.

d. Assess the number of people required to assure all have essential productive roles.

e. Consider the magnitude of doses received by team members in transit to work location.

EP-AD-000-125, Revision 7, Page 10 of 10